SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. New findings on the cardiovascular benefits of SGLT2 inhibitors are crucial for nephrologists managing patients with kidney disease and cardiovascular risks.
More from ASNRT News Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.
All news · ASNRT home
Arab Society of Nephrology and Renal Transplantation
The Arab Society of Nephrology and Renal Transplantation (ASNRT) is a non-profit scientific society founded in 1985, advancing kidney care across 22 Arab countries through research, education, and clinical practice. The society operates through specialized committees, biannual congresses, the Arab Journal of Nephrology and Transplantation (AJNT), and a network of partner societies including the International Society of Nephrology (ISN), African Federation of Nephrology (AFRAN), and the International Society for Peritoneal Dialysis (ISPD).
Email: [email protected]
Languages: English, العربية